Warburg Pincus acquires stake in Polyplus

Warburg Pincus has made an investment in Polyplus, a developer of technology used in gene and cell therapy.

29 April 2020•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles